الخميس 10 محرم 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| A Randomized, Double Blinded, Comparative Observational Interventional Study to Assess The Safety And Immunogenicity Of Hepatitis B Vaccine In Newborns / Adolescents And Adults Six Months Post Vaccination | Arab Company for Pharmaceutical products | Ongoing | EUVAX B VACCINE | 4 | HBV-001 | King Fahad Medical City (Riyadh),General Medical Polyclinic (Jeddah) ,Dafa Special Polyclinic |
| Impact of using Zinc Oxide versus Moist Exposed Wound Ointment (MEBO) in treatment of second stage pressure ulcer: A randomized control clinical trial | King Abdullah Medical City (Makkah) | Ongoing | MEBO and Zinc oxide topical | 3 | Version 5 | King Abdullah Medical City (Makkah) |
| A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety and Efficacy of Subcutaneous Implants of Afamelanotide in Patients with Xeroderma Pigmentosum (XP) | CLINUVEL EUROPE LIMITED | Terminated | Afamelanotide | 2a | CUV156 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib | Novartis | Ongoing | remibrutinib | 3 | CLOU064C123 | King Faisal Specialist Hospital and Research Center (Jeddah) - King Abdulaziz Medical City NG (Jeddah) - King Abdulaziz Medical City NG (Riyadh) |
| An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II | KalVista Pharmaceuticals Ltd | Ongoing | Sebetralstat | 3 | KVD900-302 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A prospective observational international study of cabozantinib tablets in combination with nivolumab as first-line treatment of advanced renal cell carcinoma in adults | Ipsen Pharma | Ongoing | Cabozantinib | 4 | CLIN-60000 | King Abdulaziz Medical City NG (Riyadh) |
| A Phase 3, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab in Participants with Fistulizing, Perianal Crohn’s Disease | Janssen Research & Development LLC | Ongoing | Guselkumab | 3 | CNTO1959CRD3005 | King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Specialist Hospital (Dammam), King Saud Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
| A Randomized, Double-blind, Multicenter Study to Determine the Effect of Triheptanoin Compared with Even-chain, Medium-chain Triglycerides (MCT) on Major Clinical Events (MCEs) in Pediatric Patients with Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) | Ultragenyx Pharmaceutical Inc | Ongoing | UX007/triheptanoin, Medium-chain Triglycerides (MCT),Dextrose. Monosaccharide. Blood Glucose-Elevating Agents. | 3 | UX007-CL30 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A non-interventional, multinational,observational study with isatuximabin patients with relapsed and/orrefractory multiple myeloma (RRMM) | Sanofi | Ongoing | SARCLISA® ( isatuximab - irfc ) | 4 | OBS16577 | Mouwasat Hospital (Dammam),King Faisal Specialist Hospital and Research Center (Jeddah),King Abdulaziz Medical City NG (Jeddah),King Abdulaziz Medical City NG (Riyadh) |
| International collaborative treatment protocol for infants under one year with KMT2Arearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia (Interfant-21) | King Abdullah International Medical Research Center (KAIMRC) | Ongoing | BLINATUMOMAB | 3 | SCT22R/016/12 | King Abdulaziz Medical City NG (Riyadh),King Abdulaziz Medical City NG (Jeddah) |
تاريخ آخر تحديث: 08/05/2025 بتمام الساعة 03:17 مساء بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.